RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Menadione Induced Apoptosis in MKN45 Cells via Down-regulation of Survivin

      한글로보기

      https://www.riss.kr/link?id=A106095868

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Menadione is known as an anti-tumor factor. Many studies have reported the potential anti-cancer role of menadione against a range of cancer cell lines. In this study, the anti-cancer effects of menadione and the underlying molecular signaling involve...

      Menadione is known as an anti-tumor factor. Many studies have reported the potential anti-cancer role of menadione against a range of cancer cell lines. In this study, the anti-cancer effects of menadione and the underlying molecular signaling involved in apoptosis was investigated in gastric cancer cell lines. The menadione treatment decreased the cell viability of MKN45 gastric cancer cells. The decreased cell viability was attributed to the induction of apoptosis, which was confirmed by the results indicating the activation of caspase-3 and -7 and the cleavage of PARP in Western blotting. The upstream regulatory molecules involved in apoptosis were investigated further and it was discovered that menadione reduced the expression of survivin, an inhibitor of upstream apoptosis proteins. In addition, a transcription factor β–catenin, which is known to regulate survivin expression, was down-regulated by menadione. A previous report showed that menadione inhibited XIAP expression to induce apoptosis and induced G2/M cell cycle arrest in AGS cells. This study elucidated another inhibitory mechanism of menadione against gastric cancer cells in a different cell line. Although further studies will be needed, the inhibitory mechanism demonstrated in this study will help better understand the anti-cancer effects of menadione.

      더보기

      참고문헌 (Reference)

      1 Li F, "Transcriptional analysis of human survivin gene expression" 344 (344): 305-311, 1999

      2 Osada S, "The utility of vitamin K3(menadione)against pancreatic cancer" 28 : 45-50, 2008

      3 De Almagro MC, "The inhibitor of apoptosis(IAP)proteins are critical regulators of signaling pathways and targets for anti-cancer therapy" 34 : 200-211, 2012

      4 Mobahat M, "Survivin as a preferential target for cancer therapy" 15 : 2494-2516, 2014

      5 Altieri DC, "Survivin apoptosis : an interloper between cell death and cell proliferation in cancer" 79 : 1327-1333, 1999

      6 Chen X, "Survivin and tumorigenesis : molecular mechanisms and therapeutic strategies" 7 : 314-323, 2016

      7 Sah NK, "Structural, functional and therapeutic biology of survivin" 244 : 164-171, 2006

      8 Gritsko T, "Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells" 12 : 11-19, 2006

      9 Esteve PO, "Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells" 282 : 2615-2625, 2007

      10 Al-Suhaimi E, "Molecular mechanisms of leptin and pro-apoptotic signals induced by menadione in HepG2 cells" 21 : 582-588, 2014

      1 Li F, "Transcriptional analysis of human survivin gene expression" 344 (344): 305-311, 1999

      2 Osada S, "The utility of vitamin K3(menadione)against pancreatic cancer" 28 : 45-50, 2008

      3 De Almagro MC, "The inhibitor of apoptosis(IAP)proteins are critical regulators of signaling pathways and targets for anti-cancer therapy" 34 : 200-211, 2012

      4 Mobahat M, "Survivin as a preferential target for cancer therapy" 15 : 2494-2516, 2014

      5 Altieri DC, "Survivin apoptosis : an interloper between cell death and cell proliferation in cancer" 79 : 1327-1333, 1999

      6 Chen X, "Survivin and tumorigenesis : molecular mechanisms and therapeutic strategies" 7 : 314-323, 2016

      7 Sah NK, "Structural, functional and therapeutic biology of survivin" 244 : 164-171, 2006

      8 Gritsko T, "Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells" 12 : 11-19, 2006

      9 Esteve PO, "Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells" 282 : 2615-2625, 2007

      10 Al-Suhaimi E, "Molecular mechanisms of leptin and pro-apoptotic signals induced by menadione in HepG2 cells" 21 : 582-588, 2014

      11 Tetef M, "Mitomycin C and menadione for the treatment of lung cancer : a phase II trial" 13 : 157-162, 1995

      12 Li MX, "Mitochondria and apoptosis : emerging concepts" 7 : 42-, 2015

      13 Tariq M, "Menadione protects gastric mucosa against ethanol-induced ulcers" 56 : 393-399, 2005

      14 Kim YJ, "Menadione induces the formation of reactive oxygen species and depletion of GSH-mediated apoptosis and inhibits the FAK-mediated cell invasion" 387 : 799-809, 2014

      15 Lee MH, "Menadione induces apoptosis in a gastric cancer cell line mediated by down-regulation of X-linked inhibitor of apoptosis" 9 : 2437-2443, 2016

      16 Lee MH, "Menadione induces G2/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1" 8 : 5246-5255, 2016

      17 Hassan GS, "Menadione" 38 : 227-313, 2013

      18 Torre LA, "Global cancer statistics, 2012" 65 : 87-108, 2015

      19 Romero-Gallo J, "Effect of Helicobacter pylori eradication on gastric carcinogenesis" 88 : 328-336, 2008

      20 Tang C, "Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis" 20 : 249-258, 2009

      21 Span PN, "Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?" 52 : 1693-1700, 2006

      22 Igney FH, "Death and anti-death : tumour resistance to apoptosis" 2 : 277-288, 2002

      23 Oztopcu-Vatan P, "Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells" 67 : 1003-1009, 2015

      24 Chantalat L, "Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions" 6 : 183-189, 2000

      25 Li F, "Control of apoptosis and mitotic spindle checkpoint by survivin" 396 : 580-584, 1998

      26 Siegel RL, "Cancer statistics" 66 : 7-30, 2016

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2026 평가예정 재인증평가 신청대상 (재인증)
      2020-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2017-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2016-01-01 평가 등재후보학술지 유지 (계속평가) KCI등재후보
      2015-01-08 학술지명변경 한글명 : 대한임상검사학회지 -> 대한임상검사과학회지
      외국어명 : 미등록 -> Korean Journal of Clinical Laboratory Science
      KCI등재후보
      2014-06-25 학회명변경 한글명 : 대한임상검사학회 -> 대한임상검사과학회
      영문명 : The Korean Society for Clinical Laboratory Science -> Korean Society for Clinical Laboratory Science
      KCI등재후보
      2014-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2004-12-17 학회명변경 영문명 : The Korean Society Of Biomedical Laboratory Science -> The Korean Society for Clinical Laboratory Science
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.43 0.43 0.36
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.31 0.28 0.34 0.12
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼